F. Hoffmann-La Roche Ltd: European Commission approves Roche s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for people with HER2-positive breast cancer
1,2,3
administered under the skin in just minutes compared to hours with intravenous (
IV) infusion of Perjeta plus Herceptin
4,5,6
Approval is based on results from the pivotal phase III FeDeriCa trial, which showed that Phesgo delivered
non-inferior
7
Basel, 23 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Phesgo
, a fixed-dose combination of Perjeta (pertuzumab) and Herceptin (trastuzumab) with hyaluronidase, administered by subcutaneous (SC; under the skin) injection for the treatment of early and metastatic HER2-positive breast cancer.
F. Hoffmann-La Roche Ltd
European Commission approves Roche’s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for people with HER2-positive breast cancer
European Commission approves Roche’s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for people with HER2-positive breast cancer
Subcutaneous administration is preferred by patients, physicians and healthcare providers, and is associated with a reduction in healthcare costs
1,2,3
administered under the skin in just minutes compared to hours with intravenous (
IV) infusion of Perjeta plus Herceptin
4,5,6
Approval is based on results from the pivotal phase III FeDeriCa trial, which showed that Phesgo delivered
This press release was orginally distributed by ReleaseWire
Philadelphia, PA (ReleaseWire) 12/10/2020 Frontida BioPharm, Inc., a pharmaceutical Contract Development and Manufacturing Organization based in Philadelphia and Chicago areas, has been granted full certifiable recognition by The Eastern Minority Supplier Development Council as a Minority-Owned Business Enterprise (certified MBE).
The Eastern Minority Supplier Development Council (EMSDC) is a 501(c)(3) non-profit organization and nationally recognized affiliate of the National Minority Supplier Development Council (NMSDC). The EMSDC certifies minority-owned, operated and controlled businesses throughout Pennsylvania, Southern New Jersey, and Delaware. The NMSDC is the only organization capable of providing this specific validation and certification throughout the U.S. It advocates business opportunities for certified minority business enterprises and connects them to corporate members who maintain initiatives to sup